Mail

UK markets close in 1 hour 55 minutes

FTSE 100
7,058.74
+149.98(+2.17%)
FTSE 250
17,753.39
+468.51(+2.71%)
AIM
816.00
+7.27(+0.90%)
GBP/EUR
1.1469
-0.0047(-0.41%)
GBP/USD
1.1380
+0.0061(+0.54%)
BTC-GBP
17,621.32
+599.10(+3.52%)

How will the interest rate rises affect your mortgage?

Rates have leapt up over 4% since December, but what does this mean for you?

Centessa Pharmaceuticals plc (CNTA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

4.0200

-0.0400

(-0.99%)

As of 09:31AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	379.24M
Enterprise value	-37.52M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	0.91
Enterprise value/revenue	N/A
Enterprise value/EBITDA	3.65

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	-74.48%
S&P500 52-week change ³	-15.36%
52-week high ³	17.7300
52-week low ³	2.8850
50-day moving average ³	4.3842
200-day moving average ³	6.9422

Share statistics

Avg vol (3-month) ³	169.94k
Avg vol (10-day) ³	181.73k
Shares outstanding ⁵	94.34M
Implied shares outstanding ⁶	N/A
Float ⁸	40.17M
% held by insiders ¹	3.31%
% held by institutions ¹	76.46%
Shares short (14 Sept 2022) ⁴	2.66M
Short ratio (14 Sept 2022) ⁴	11.5
Short % of float (14 Sept 2022) ⁴	N/A
Short % of shares outstanding (14 Sept 2022) ⁴	2.82%
Shares short (prior month 14 Aug 2022) ⁴	2.71M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2021
Most-recent quarter (mrq)	29 Jun 2022

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-22.48%
Return on equity (ttm)	-43.77%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-209.4M
Net income avi to common (ttm)	-220.09M
Diluted EPS (ttm)	-2.2950
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	484.16M
Total cash per share (mrq)	5.13
Total debt (mrq)	67.4M
Total debt/equity (mrq)	16.05
Current ratio (mrq)	15.48
Book value per share (mrq)	4.46

Cash flow statement

Operating cash flow (ttm)	-199.49M
Levered free cash flow (ttm)	-110.88M